MedPath

Evaluation of the effect of oral levofloxacin on chronic endometritis in patients

Phase 3
Conditions
Endometritis.
Inflammatory disease of uterus, unspecified
N71.9
Registration Number
IRCT20220413054524N1
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Females with chronic endometritis with fetal transfer failure confirmed by histology using histology

Exclusion Criteria

Sensitivity to doxycycline
Allergy to metronidazole
Glucose 6 phosphate dehydrogenase deficiency

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometritis. Timepoint: Before the intervention and the next menstrual cycle. Method of measurement: Perform a biopsy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath